As manufacturers of e-cigarettes and certain other tobacco products face a September 9, 2020, deadline to apply to the U.S. Food and Drug Administration to keep their products on the market, six leading public health and medical organizations today urged the FDA not to authorize the sale of any flavored product
Sacramento, CA – Medicine is not the only venue for fighting cancer.
LANETT, AL – August 6, 2020 – With the COVID-19 pandemic shining a bright light on the importance of affordable and accessible health insurance coverage, Medicaid continues to be a central topic of discussion among public health advocates, hospital and health systems administrato
Dan and Linda Hart understand what it means to watch a loved one battle cancer, to be a caregiver for a spouse going through the disease.
Missouri voters stood up for public health on Tuesday and passed a ballot measure to increase access to health insurance coverage for more Missourians through the state’s Medicaid program, following on the heels of Oklahomans who made the same move at the end of June.
Jefferson City, MO — Missourians approval of Amendment 2 will improve health outcomes and reduce cancer disparities for 230,000 citizens who will gain access to health insurance coverage through the state’s Medicaid program.
SACRAMENTO, CA - With the Assembly Health Committee set to take a historic vote on Senate Bill (SB) 793 (Hill D-San Mateo) to finally end the sale of all -flavored tobacco products this Tuesday, public health advocates believe the tobacco industry’s all-out lobbying and advertisi
Today the U.S. House of Representatives voted on an FY 2021 spending bill that includes a $5.5 billion funding increase for the National Institutes of Health (NIH). Half of the increase would be considered emergency funding and the other half would be divided among the various institutes, including a nearly $470 million funding boost for the National Cancer Institute (NCI).
ST. PAUL, Minn. – Three pieces of legislation that reduce Minnesota’s cancer burden go into effect August 1st.
Today President Trump signed executive orders on pharmaceutical rebates, prescription drug importation and an International Pricing Index (IPI) or “Most Favored Nation” Model. The following is a response to the executive orders from the American Cancer Society Cancer Action Network (ACS CAN).